Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:42 AM
Ignite Modification Date:
2025-12-25 @ 2:42 AM
NCT ID:
NCT06022133
Eligibility Criteria:
Inclusion Criteria:
* 24h blood pressure \> 130/80 mmHg under antihypertensive treatment with three agent, one of these being diuretic. Blood pressure measurement completed after observed intake of antihypertensive medication.
* unchanged antihypertensive treatment for three months
* estimated glomerular function \>45 mL/min/1.73 m2
Exclusion Criteria:
* Heart failure assessed from NYHA classification (grade 3-4)
* Presence of clinically significant peripheral edema
* In treatment for obstructive sleep apnea
* Chronic obstructive pulmonary disease (FEV1 \<50%)
* Antihypertensive therapy that can not be taken once daily
* Pregnancy or breastfeeding
* Β-albumin \<34 g / l
* U-albumin creatinine ratio\> 1000 mg / g
* INR\> 1.2 (if marevan treatment: ALAT\> 200)
* Gluten allergy (dietary guidelines are not adjusted to this group)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Maximum Age:
70 Years
Study:
NCT06022133
Study Brief:
Protocol Section:
NCT06022133